Lisata Therapeutics, Inc.
LSTA
$1.09
-$0.04-3.54%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.44M | 13.06M | 15.96M | 19.00M | 21.97M |
| Total Receivables | 200.00K | 200.00K | 700.00K | 1.20M | 1.20M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 370.00K | 760.00K | 1.05M | 1.38M | 1.71M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 11.01M | 14.02M | 17.70M | 21.58M | 24.89M |
|
|
|||||
| Total Current Assets | 11.01M | 14.02M | 17.70M | 21.58M | 24.89M |
| Net Property, Plant & Equipment | 14.00K | 16.00K | 18.00K | 22.00K | 95.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | 139.00K | 157.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 23.00K | 23.00K | 23.00K | 23.00K |
| Total Assets | 11.03M | 14.06M | 17.74M | 21.76M | 25.16M |
|
|
|||||
| Total Accounts Payable | 836.00K | 510.00K | 1.02M | 619.00K | 782.00K |
| Total Accrued Expenses | 2.05M | 2.32M | 2.05M | 3.95M | 3.48M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | 47.00K |
| Total Finance Division Other Current Liabilities | 100.00K | 485.00K | -- | -- | -- |
| Total Other Current Liabilities | 100.00K | 485.00K | -- | -- | -- |
| Total Current Liabilities | 2.99M | 3.32M | 3.07M | 4.57M | 4.31M |
|
|
|||||
| Total Current Liabilities | 2.99M | 3.32M | 3.07M | 4.57M | 4.31M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 50.00K | 72.00K | 72.00K | 72.00K | 72.00K |
| Total Liabilities | 3.04M | 3.39M | 3.14M | 4.64M | 4.39M |
|
|
|||||
| Common Stock & APIC | 581.04M | 580.80M | 580.25M | 579.82M | 579.24M |
| Retained Earnings | -572.07M | -569.14M | -564.65M | -561.70M | -557.45M |
| Treasury Stock & Other | -725.00K | -729.00K | -745.00K | -750.00K | -758.00K |
| Total Common Equity | 8.24M | 10.93M | 14.86M | 17.37M | 21.03M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.24M | 10.93M | 14.86M | 17.37M | 21.03M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -254.00K | -254.00K | -254.00K | -254.00K | -254.00K |
| Total Equity | 7.99M | 10.67M | 14.60M | 17.12M | 20.78M |
|
|
|||||